Conference Coverage
ReachMD brings you the latest research, announcements, and conversations from the most important medical conferences around the world. Join us on the conference floor with keynote speakers, experts, and opinion leaders.
Episodes 271-285 of 480
Reviewing Telehealth Rules & Regulations: An Update from the Psych Congress
Psych Congress Action CenterReviewing Telehealth Rules & Regulations: An Update from the Psych Congress
Exploring the Latest on Lipids: Updates on Lp(a) in Preventative Cardiology
Heart MattersExploring the Latest on Lipids: Updates on Lp(a) in Preventative Cardiology
A First Clinical Trial Testing the Use of an H2S Donor After Heart Attack
ACC Action CenterA First Clinical Trial Testing the Use of an H2S Donor After Heart Attack
Reductions in LVOT Gradients, NYHA Class, & NT-proBNP with Cardiac Myosin Inhibitor in HCM
ACC Action CenterReductions in LVOT Gradients, NYHA Class, & NT-proBNP with Cardiac Myosin Inhibitor in HCM
Novel Form of CV Research with Dietary Education in the Grocery Store
ACC Action CenterNovel Form of CV Research with Dietary Education in the Grocery Store
Beginning of an Era: Treatment of Elevated Lp(a)
ACC Action CenterBeginning of an Era: Treatment of Elevated Lp(a)
- advertisement
PCSK9i Reduces Plaque Burden in Coronary Arteries
ACC Action CenterPCSK9i Reduces Plaque Burden in Coronary Arteries
Study with ASO Targeting ANGPTL3 mRNA Highlights Importance of Rigorous Evaluation of New Therapies
ACC Action CenterStudy with ASO Targeting ANGPTL3 mRNA Highlights Importance of Rigorous Evaluation of New Therapies
Reduction of Bleeding with Tranexamic Acid After Noncardiac Surgery
ACC Action CenterReduction of Bleeding with Tranexamic Acid After Noncardiac Surgery
Cardiac Myosin Inhibitor Sustainably Reduces LVOT Gradient in HCM
ACC Action CenterCardiac Myosin Inhibitor Sustainably Reduces LVOT Gradient in HCM
Impact of New First-in-Class Medical Therapy in Obstructive HCM
ACC Action CenterImpact of New First-in-Class Medical Therapy in Obstructive HCM
Treatment of Chronic Hypertension Reduces Adverse Pregnancy Outcomes
ACC Action CenterTreatment of Chronic Hypertension Reduces Adverse Pregnancy Outcomes
- advertisement
Updates in the New AHA/ACC/HFSA Heart Failure Guideline
ACC Action CenterUpdates in the New AHA/ACC/HFSA Heart Failure Guideline
Cardiac Myosin Inhibitor Reduces Need for Septal Reduction Therapy in Obstructive HCM
ACC Action CenterCardiac Myosin Inhibitor Reduces Need for Septal Reduction Therapy in Obstructive HCM
Crohn's & Colitis Congress 2022: Looking Back & Looking Ahead with the 2023 Chair
Crohn’s & Colitis Foundation PerspectivesCrohn's & Colitis Congress 2022: Looking Back & Looking Ahead with the 2023 Chair
